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Abstract.  Binding of ligands to the extracellular re- 
gion of the erythrocyte transmembrane protein 
glycophorin A  induces a  decrease in membrane defor- 
mability. Since the property of membrane deformabil- 
ity is regulated by the skeletal proteins on the cyto- 
plasmic side of the membrane, this suggests that 
ligand binding may initiate a transmembrane signal. To 
further study this process,  we examined which do- 
mains of the extracellular region of glycophorin are in- 
volved in signal transduction and whether the cytoplas- 
mic domain of the molecule is necessary for 
transmitting the signal.  Using the ektacytometer, we 
compared the effect on deformability of four monoclo- 
nal antibodies that detect different epitopes on 
glycophorin A. We found that 9A3  (which recognized 
the amino terminus of glycophorin) caused a  5.8-fold 
increase in rigidity, R-10 and  10F7  (which recognized 
epitopes in the mid-region of the extracellular domain) 
caused a  10.8-fold  increase in rigidity and B14  (which 
binds to glycophorin close to the membrane) caused a 
18-fold increase in rigidity. Further, a  direct relation- 
ship was observed between the degree of antibody- 
induced rigidity and the amount of glycophorin A  that 
became associated with the skeletal proteins in a  Tri- 
ton shell assay. In Miltenberger V  erythrocytes, which 
contain a  hybrid sialoglycoprotein with no cytoplasmic 
domain, antibody binding did not induce an increase 
in rigidity. These results imply that glycophorin A  is 
capable of a  modulatable form of transmembrane sig- 
naling that is determined by the extracellular domain 
to which the ligand binds, and the cytoplasmic domain 
of glycophorin A  is crucial for this process. 
ECEPTOR binding initiates numerous and varied bio- 
logical responses in many cell systems. The molecu- 
lar processes by which ligand binding generates trans- 
membrane signaling through receptor molecules appear to 
vary. One well-described mechanism entails ligand-induced 
changes in the associations of integral and skeletal mem- 
brane proteins. In platelets, ligand binding and stimulation 
of platelets causes an increased association of membrane- 
spanning glycoproteins IIb and IIIa with the actin cytoskele- 
ton  (17, 28,  29).  In neutrophils,  a  similar lectin-induced 
association of glycoproteins and skeletal components occurs 
which may modulate cell  motility (34).  While the  basic 
mechanism  of ligand-induced protein-protein  association 
has been established as a transmembrane signaling process, 
important details remain to be  defined. For example,  the 
effect of ligand binding to different extracellular domains has 
not been studied nor has the role of the cytoplasmic domain. 
This study attempts to address these issues using the erythro- 
cyte as a model system. 
The bases for the present study are our earlier findings that 
transmembrane  signaling can  indeed be  induced through 
changes in glycoprotein-membrane interactions in the red 
blood cell. We found that membrane deformability was mark- 
edly decreased  in  erythrocytes that  were  pretreated  with 
ligands specific for the transmembrane protein, glycophorin 
A (also known as sialoglycoprotein ct; 4), but remained nor- 
mal in the presence of ligands specific for other cell surface 
components such as band 3 and blood group antigens A and 
B (10). The decrease in membrane deformability appeared 
to depend upon a transmembrane process, and not upon a 
rigidity-inducing lattice on the outside surface of the cell be- 
cause a  monovalent Fab of an anti glycophorin IgG pro- 
duced decreased deformability (10). Since the erythrocyte 
skeletal proteins play an important role in determining mem: 
brane deformability (9,  12,  16, 25), we looked for a ligand- 
induced change in the associations of glycophorin with skel- 
etal proteins. In Triton X-100-insoluble residues, we found 
that the partitioning of glycophorin A with the skeletal pro- 
teins increased after binding of ligands specific for  glycopho- 
rin A (10), These results implied that a form of transmem- 
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glycophorin A, and results in changes in the cellular prop- 
erty of membrane deformability. 
To further study the mechanism by which ligand binding 
to glycophorin A can modulate membrane deformability, we 
asked what domain(s) along the extracellular portion of the 
molecule was involved in the process, and whether the cyto- 
plasmic peptide plays a  role in signal transduction. Using 
monoclonal antibodies that detect different epitopes on the 
extracellular region of glycophorin A, we found that every 
antibody tested induced membrane rigidity, but the degree 
of rigidity varied: the closer the binding epitope was to the 
membrane, the greater the degree of rigidity induced. More- 
over, there was a direct relationship between the degree of 
rigidity and the amount of glycophorin A that was associated 
with the skeletal proteins.  To determine whether the cyto- 
plasmic domain has a role in these ligand-induced changes 
in membrane deformability, we studied homozygous Milten- 
berger V erythrocytes, which contain a hybrid sialoglycopro- 
tein (~t-/5; 6, 37) composed of glycophorins A and B (also 
known as sialoglycoprotein/5; 4) but with no cytoplasmic do- 
main (22).  The Miltenberger V cells exhibited little change 
in membrane deformability after ligand binding,  implying 
that the cytoplasmic region of glycophorin A is essential for 
signal transduction. 
Materials and Methods 
Reagents 
Dextran was purchased from Pharmacia Fine Chemicals (Uppsala, Sweden); 
anti-N and anti-M from Ortho Diagnostic Systems, Inc.  (Westwood, MA). 
The monoclonal antibodies used in these studies were all of the IgG class 
and have been described in detail elsewhere (5,  7,  8,  11). In brief, 9A3 
recognizes an epitope involving the first NH2-terminal amino acid and is 
specific for blood group antigen M; R-10 and l0 F7 bind to the 39 amino 
acid trypsin-sensitive NH2-terminal peptide of M or N erythrocytes (5, 8, 
ll); B-14 recognizes an epitope between residues 56 and 67, close to the 
membrane (31); and BRIC-10 binds to the NH2 terminus of glycophorin C 
(sialoglycoprotein [3; 7). 
Deformability Measurements 
After obtaining informed consent, blood from normal volunteers and from 
an individual with Miltenberger V blood type was drawn into acid-citrate- 
dextrose and the erythrocytes were collected and washed three times in 
5 mM "Iris,  140 mM NaCI,  pH 7.4.  The cells were then resuspended to 
0.5 % hematocrit in 3 ml of dextran (40,000 tool wt, 25 g/100 ml in 10 mM 
phosphate buffer, pH 7.4) and examined by ektacytometry, a laser diffraction 
method previously described (26). Briefly,  suspended cells are exposed to 
an increasing shear stress (0-400 dyn/cm  2) and the change in their laser 
diffraction pattern from a circle to an ellipse is monitored. Photometric mea- 
surement of light intensities at two points in the diffraction image produces 
a signal, designated the deformability index, which quantitates cell elliptic- 
ity.  By an automatic  image analysis system, the deformability index is 
recorded as a continuous function of applied shear stress. The curve thus 
produced is a measure of the ability of the ceils to deform under defined 
fluid  stresses. 
To evaluate the effect of antibodies on deformability, washed erythrocytes 
were resuspended to 0.5% hematocrit in dextran solution containing mono- 
clonal antibodies (5-360 p,g/ml).  The suspensions were incubated for 30 
rain at room temperature and then examined in the ektacytometer. 
Hemagglutination Assay 
Equal volumes of anti-M, anti-N, or monoclonal antibodies and a 4% saline 
suspension of washed red cells were incubated at room temperature for 1 h. 
The cell suspensions were then centrifuged at 1,000 rpm for 10 s and exam- 
ined macroscopically for hemagglutination. 
Triton X-100  Extraction of  Erythrocytes 
Erythrocytes were extracted with Triton X-100  using a  method modified 
from that first described by Sheetz (33). In brief, freshly drawn erythroeytes 
were washed twice in 140 mM NaCI,  10 mM sodium phosphate, pH 7.4. 
1.1 ml of washed cells (hematocrit 70%) was then lysed in Triton X-100 (100 
mg/10 ~° cells) in  140  mM KCI, 20  mM Hepes, 0.5  mM MgC12,  1 mM 
EGTA, 0.05 mM CaCI2, 2 mM reduced glutathione, and 1 mM DFP. This 
lysate was layered on a linear sucrose density gradient (10-60%) and cen- 
trifuged for 1 h at 22,000 rpm in an ultracentrifuge (model L3-50; Beckman 
Instruments, Inc., Fullerton, CA). The single visible band on the gradient 
was collected and resuspended in  140 mM KCI, 20 mM Hepes,  1 mM 
EDTA,  2  mM  reduced glutathione, and 0.03  mM phenylmethylsulfonyl 
fluoride (PMSF; pH 7.4) and centrifuged at 22,000 rpm for 30 min. The 
resulting pellet was solubilized and analyzed by electrophoresis  as described 
below. 
To evaluate  Triton extractability after ligand binding,  1.1  ml of washed 
cells (hematocrit 70%) was resuspended in 58.2 ml in dextran (40,000  mol 
wt, 25 g/100 ml in 10 mM phosphate buffer, pH 7.4) containing 7.5-180.0 
~tg/ml monoclonal antibody. The cells were incubated for 30 min at room 
temperature, then pelleted at  2,000  rpm  for 5  min in a  Sorvall  RC-2B 
(DuPont Instruments, Sorvall Biomedical Division, Newton, CT).  These 
pretreated erythrocytes were then processed as described above. 
SDS-PAGE 
Samples for electrophoresis were solubilized in 0.5 M Tris-HCl (pH 6.8), 
1.25%  SDS, and 0.38 M dithiothreitol (DTT), heated to 100°C  for 2 min, 
and analyzed in the discontinuous system described by Laemmli (19) on 
slab gels composed of a separating gel of 10%  acrylamide and a stacking 
gel of 3 % acrylamide. After electrophoresis, the gels were fixed and stained 
for carbohydrate with periodic acid-Schiff  reagent (7). Quantitation of peri- 
odic acid-Schiff  reagent-positive bands was obtained by gel scanning at 550 
nm using a spectrophotometer (model DU-8; Beckman Instruments, Inc.). 
Quantitation of Spectrin 
The amount of spectrin in the Triton-insoluble residues was determined as 
previously described (1). The washed Triton shells were dissolved in SDS 
and subjected to electrophoresis through 3.5-17.0%  polyacrylamide slab 
gels using the Fairbanks buffer system (13). The slabs were then stained with 
Coomassie Brilliant Blue R250  and destained until the background was 
colorless. The bands corresponding to spectrin were excised, the dye was 
eluted in 25 % (vol/vol) pyridine in water, and the absorbance of the spectrin 
eluate was measured at 605 nm (15). 
Results 
Effect of Glycophorin A-specific Antibodies on 
Membrane Deformability 
To study which domains along the extracellular portion of 
glycophorin A play a role in modulating membrane deform- 
ability, we used monoclonal antibodies as probes. The bind- 
ing sites  for these antibodies  are depicted in Fig.  1.  This 
figure is a schematic diagram of glycophorin A as it traverses 
the lipid bilayer with its amino terminus on the cell surface 
and its carboxy terminus within the cytoplasm (18,  21,  32, 
36). The antibody, with an epitope most distal to the lipid 
bilayer was 9A3. This antibody has specificity for the blood 
group antigen  M  and  recognizes  an  epitope  that involves 
amino acid 1 but not amino acid 5 (8). RI0 and 10F7 bind 
closer to the lipid bilayer than 9A3 but do not bind to erythro- 
cytes pretreated with trypsin (5, 8, 11). B14 dele.cts an epitope 
between residues 56 and 67, a region of the sialoglycoprotein 
closely adjacent to the bilayer (31). 
The effect on deformability of antibody binding was mea- 
sured by ektacytometry. Initially, dose response curves were 
done with each antibody to determine the concentration at 
which the maximal rigidity occurred. The effect of increas- 
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Figure  1.  Schematic diagram of glycophorin A with the antibody 
binding sites. The peptide  backbone with  its  15 O-linked  (o) and 
1  N-linked  (zx) tetrasaccharides  is shown  traversing  the lipid  bi- 
layer. The blood group antigens  M and N are determined by varia- 
tions within the first five amino acids in the amino terminal  end of 
the molecule.  The monoclonal antibody 9A3 has anti-M specificity 
and binds to the amino terminus.  Antibodies R-10 and 10F7 bind 
in the mid-region of the extracellular  portion of glycophorin A dis- 
tal to the trypsin cleavage site. BI4 detects an epitope closely adja- 
cent to the lipid bilayer,  between residues  56 and 67. 
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Figure 3. Effect of 9A3 on the deformability  of MM, MN, and NN 
erythrocytes.  Antibody-treated  NN erythrocytes (o),  which lack 
the antigenic  determinant for 9A3, and erythrocytes without anti- 
body (control RBC,  o) had normal deformability in response to 
low shear stress.  MN cells (m) and MM cells (o) with bound 9A3 
required greater amounts of shear stress to produce the same degree 
of deformation as cells without bound antibody. MN cells with 9A3 
bound were 2.5 times more rigid than normal, and MM cells with 
bound 9A3 were 4.5 times  more rigid. 
ing concentrations of 9A3 on the deformability of MM eryth- 
rocytes is shown in Fig. 2. In this figure,  the deformability 
index is plotted as a  function of the logarithm of the shear 
stress.  It can be seen that the cells treated  with  increasing 
concentrations  of 9A3  required  greater  amounts  of shear 
stress  to produce the same degree of deformation as cells 
without antibody. Since the lines are parallel, one can calcu- 
late that cells treated with 5  I.tg/ml of 9A3 required  1.7-fold 
0.7 
0.6 
=o,  /...-//./ 
pl  m  r  ~  ~ 
,o, 
./Yi'll 
• [  ' 
0  I  I  L  L  mill  I  I  i  i  L  l  I  II 
10  20  50  100  200  500  1000 
,S4~ear  stress  (dynes/om  z) 
Figure 2.  Effect of 9A3 on deformability of MM erythrocytes. The 
deformability of cells without antibody (control RBC, o) was nor- 
mal in response  to low shear stress.  Cells treated  with  increasing 
concentrations of 9A3 required  greater amounts of shear stress  to 
produce the same degree of deformation as cells without antibody. 
The lines are parallel;  thus cells  treated  with 5 pg/ml of 9A3 (i) 
required  1.7-fold greater shear stress than cells without antibody to 
reach equivalent deformation at all points along the curve, indicat- 
ing that these cells were 1.7 times more rigid than normal. 10 Itg/ml 
of9A3 (c~) induced a relative rigidity of 2.3; 20 pg/ml (O) induced 
a relative  rigidity  of 3.7; and 40 (A) and 160 (zx) pg/ml induced a 
relative rigidity of  4.5. The maximal effect was observed at 40 pg/ml. 
The deformability  index is plotted as a function of the logarithm of 
the shear stress. 
greater  shear  stress  than  cells  without  antibody  to  reach 
equivalent deformation at all points along the curve, indicat- 
ing that these cells were  1.7 times more rigid than normal. 
Erythrocytes treated  with  10  pg/ml  were  2.3  times  more 
rigid; those treated with 20 Ixg/ml were 3.7 times more rigid; 
and those treated with 40-160 ~tg/ml  were 4.5  times more 
rigid. Thus, increasing concentrations of 9A3 caused a dose- 
dependent increase in rigidity, and at 40 ~tg/ml the maximal 
effect was observed. Subsequent experiments were then per- 
formed using that concentration. 
The effect of 9A3 on the deformability of MM, MN, and 
NN erythrocytes is shown in Fig. 3. NN erythrocytes, which 
lack the antigenic determinant  for 9A3, were unaffected by 
incubation with this antibody. MN and MM cells pretreated 
with 9A3 required greater amounts of shear stress to produce 
the  same degree of deformation as cells  without antibody. 
MN cells  with 9A3 bound were 2.5  times more rigid than 
normal,  while  MM  cells  with  9A3 bound  were 4.5  times 
more rigid than untreated erythrocytes. 
Dose-response  curves  similar  to  those  performed  with 
9A3 were obtained with R-10,  10F7, and B14. Like 9A3, in- 
creasing concentrations of R-10,  10F7, and B14 caused dose- 
dependent increases in rigidity in the following range of anti- 
body concentrations:  10F7, 0-360 I.tg/ml;  R10, 0-240 l.tg/ 
ml, and B14, 0-200 lxg/ml.  The maximal effect on rigidity 
was observed at a  10F7 concentration of 90 pg/ml, an R-10 
concentration of 40  txg/ml,  and a  B14 concentration of 50 
pg/ml. Subsequent experiments using these antibodies were 
then performed at concentrations that induced maximum ri- 
gidity. The maximum effect of R-10 binding on deformability 
is illustrated in Fig. 4. Unlike 9A3, this antibody reacts with 
glycophorin A irrespective of its MN type. Antibody binding 
increased  the  rigidity  of MM,  NN,  and  MN erythrocytes 
10-fold. 
The relative rigidity of MM erythrocytes exposed to 9A3, 
R-10,  10F7, and B14 is depicted in Fig. 5. Control cells with 
no bound antibody have normal deformability and a relative 
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Figure 4. Effect of R-10 on the deformability ofMM, MN, and NN 
erythrocytes.  R-10 binding increased the rigidity of NN (e), MN 
(I), and MM (n) erythrocytes  10-fold. o, control RBC. 
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Figure 6.  Ligand-induced association  of glycophorin A with the 
skeletal proteins and relative membrane  rigidity. The greater the 
degree of ligand-induced  membrane rigidity, the greater the per- 
centage of glycophorin  A retained with the skeletal proteins,  e, 
erythrocytes with no antibody;  A  erythrocytes with various con- 
centrations of R-10; &, erythrocytes with various concentrations of 
9A3. 
rigidity of 1. Binding of 9A3 produces cells with a  relative 
rigidity of 5.8  +  1.5;  10F7  cells with a  relative rigidity of 
i0.8  +  1.4; R-10 cells with a relative rigidity of 10.8 +  2.1; 
and B14  cells with a  relative rigidity of 18.2  +  2.7. 
From these observations we can conclude that ligand bind- 
ing to three different regions of the extracellular peptide of 
glycophorin A  induces increased membrane rigidity.  Inter- 
estingly,  binding  of antibodies to different regions induces 
different degrees of change and the pattern observed is that 
the closer to the membrane the ligand binds the greater the 
change in rigidity. Moreover, two antibodies, 10F7 and R-10, 
which have epitopes in close proximity to one another, change 
membrane rigidity to the same degree suggesting that the re- 
gion of ligand binding determines the degree of the resulting 
change in the membrane property of deformability. 
Relationship between Membrane Rigidity and the 
Association of  Glycophorin A  with the 
Skeletal Proteins 
We next investigated whether there was a quantitative rela- 
tionship between the degree of ligand-induced membrane ri- 
gidity and ligand-induced association of glycophorin A with 
the  skeletal  proteins.  For these  studies,  MM  erythrocytes 
Figure 5. The maximum rela- 
tive  rigidity of MM erythro- 
cytes  induced by  9A3, R-10, 
10F7, and B14. Antibody bind- 
ing to diflbrent regions of gly- 
cophorin  A  induces different 
degrees  of increase  in mem- 
brane rigidity. Control eryth- 
rocytes  with  no  bound  anti- 
body  (lane  1)  have  normal 
deformability and a relative ri- 
gidity  of  1.  Binding of 9A3 
(lane 2) produces cells with a 
relative rigidity of 5.8 ___ 1.5 (n 
= 5); 10F7 (lane 3) cells with 
a  relative  rigidity  of  10.8  + 
1.4 (n =  10); R-10 (lane 4) cells with a relative rigidity of 10.8 + 
2.1 (n =  17); and B14 (lane 5) cells with a relative rigidity of 18.2 
+  2.7(n  =  6). 
were  incubated  with  various  concentrations  of the  mono- 
clonal antibodies 9A3 and RI0. Aliquots from each incuba- 
tion mixture were assayed by ektacytometry to measure mem- 
brane rigidity. Then Triton-insoluble residues were prepared 
from the liganded erythrocytes. The amount of glycophorin 
A associated with the skeletal proteins in the Triton lysates 
was quantitated by densitometry of SDS polyacrylamide gels 
stained with periodic acid-Schiff reagent. To compare differ- 
ent preparations with one another,  the  spectrin content of 
each preparation was determined as described in the Mate- 
rials and Methods section and then the amount of glycopho- 
rin A retained in the membrane skeleton of the Triton lysate 
was normalized with the spectrin content. The percentage of 
glycophorin A retained in the Triton lysate was expressed as 
a ratio of the glycophorin A retained to the total glycophorin 
A content of intact membranes. As illustrated in Fig. 6, the 
greater the degree of ligand-induced membrane rigidity, the 
greater the percentage of glycophorin A  retained  with the 
skeletal proteins.  These results imply that there is a  direct 
relationship between membrane rigidity  and enhanced  as- 
sociation of glycophorin A  with the  skeletal proteins. 
Study of  the Role of  the Cytoplasmic Domain of 
Glycophorin A 
To study whether the cytoplasmic domain of glycophorin A 
participated  in  the  transmembrane  signaling  process,  we 
used  Miltenberger V  erythrocytes.  A  periodic acid-Schiff 
reagent stain of an SDS polyacrylamide gel of erythrocyte 
membranes prepared from the homozygous Miltenberger V 
individual (F.M.) is shown in Fig. 7. In individuals homozy- 
gous for this phenotype, the red cells lack normal glycopho- 
rin A  and B and contain instead a hybrid sialoglycoprotein 
comprised of the extracellular portion of glycophorin A, the 
intramembranous portion of glycophorin B, and no cytoplas- 
mic residues. Fig. 8 shows the effect of 10F7 and R-10 on the 
deformability of both normal and Miltenberger V  erythro- 
cytes. The deformability of unliganded Miltenberger V cells 
was normal. The rigidity of normal cells after antibody bind- 
ing was markedly increased. Cells incubated with R-10 were 
13.1 times as rigid as control and those incubated with 10F7 
were 13.9 times as rigid. In contrast, the rigidity of Milten- 
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berger V cells with both 10F7 and R10 was only minimally 
increased. 
In light of these data, it was important to establish that R-10 
and 10F7 bound to Miltenberger V erythrocytes to the same 
extent as to normal cells.  Antibody binding was  evaluated 
using two techniques. The first, a standard hemagglutination 
assay, showed that 10F7 and R-10 of 1:100 dilution did indeed 
bind to Miltenberger V cells to the same degree as they did 
to control cells. These results were confirmed using a sec- 
ond, independent method in which the relative effectiveness 
of Miltenberger V and normal cells in binding R-10 was de- 
termined by assaying  the ability of supernatants  collected 
from erythrocyte and antibody incubations to induce rigidity 
in normal cells.  In this assay,  4.9  x  106 normal cells and 
9.8  ×  106 Miltenberger V  cells were separately incubated 
in aliquots of R-10 (50 lag/ml).  The number of Miltenberger 
V cells used was twice that of control cells, since the number 
of copies per cell of the hybrid sialoglycoprotein is about 
one-half that of glycophorin A  in normal cells (6,  23, 37). 
This estimation of the number of hybrid molecules per cell 
is based upon the findings that the sialic acid content of these 
particular Miltenberger V  erythrocytes is 53%  of normal, 
and that there are 100,000 molecules in a heterozygous cell 
(23, 37). After incubation, the erythrocytes were centrifuged 
and the ability of the supernatants to induce rigidity in nor- 
mal cells evaluated by ektacytometry. Both the supernatant 
from normal and Miltenberger V cells failed to induce rigid- 
ity in normal cells implying that Miltenberger V cells bound 
R-10 as effectively as normal cells. This set of experimental 
data clearly shows that the cytoplasmic domain of glycopho- 
rin A  is crucial to antibody-induced rigidity. 
Effect of Glycophorin C-specific Antibody on 
Membrane Deformability 
To determine whether ligand binding to another transmem- 
brane siatoglycoprotein with a cytoplasmic domain had an 
effect on membrane deformability, we measured deformabil- 
ity after incubation of erythrocytes with BRIC-10,  a mono- 
clonal antibody specific for glycophorin C (sialoglycoprotein 
13;  7).  We  found that  antibody  binding  to  glycophorin C 
induced  no  change  in  membrane  deformability  (data  not 
shown). 
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Figure 7. SDS polyacrylamide 
gel  of  membranes  prepared 
from  normal  (lane  A)  and 
Miltenberger  V (lane B) eryth- 
rocytes stained with PAS. Mil- 
tenberger V erythrocyte mem- 
branes have no glycophorin A 
(sialoglycoprotein ct) or gly- 
cophorin B (sialoglycoprotein 
5) but do have a hybrid sialo- 
glycoprotein  composed of gly- 
cophorins  A  and  B  (sialo- 
glycoprotein ct-~5). 
Figure 8. Effect of R-10 and 10F7 on the relative rigidity of normal 
erythrocytes and Miltenberger V erythrocytes. The deformability of 
nonliganded normal cells (lane 1 ) and Miltenberger V cells (lane 
4) was normal with a relative rigidity of |. The relative rigidity of 
normal cells after R10 (lane 2) and 10F7 (lane 3) binding was 13.1 
and 13.9, respectively. The rigidity of Miltenberger V erythrocytes 
after R-10 (lane 5) and 10F7 (lane 6) binding was only minimally 
increased. These results imply that marked increases in antibody- 
induced rigidity require the presence of the cytoplasmic domain of 
glycophorin A. 
Discussion 
Our results show that binding of ligands with specificity for 
different regions of glycophorin A  induces an  increase in 
membrane rigidity and that the magnitude of this increase is 
related to the site of ligand binding.  This differential effect 
on rigidity is not the result of differences in the amount of 
each antibody bound, since it has previously been shown that 
the number of binding sites per cell and the binding affinities 
are very similar for the antibodies used in this study (20, 24). 
We conclude from this evidence that more than one extracel- 
lular domain of the sialoglycoprotein is capable of altering 
membrane mechanical properties after ligand binding and 
that the extent of alteration is modulatable by the domain 
specificity of the ligand. The similarity in the degrees of ri- 
gidity induced by 10F7 and R-10, two antibodies with epi- 
topes which are in close proximity to one another, supports 
this conclusion. 
Based on our earlier studies and on the results presented 
in this study, we conclude that the ligand-induced alteration 
in membrane rigidity is via a transmembrane signaling pro- 
cess. We previously observed that binding monovalent Fab 
fragments  of R-10  caused  membrane  rigidity  (10).  These 
results implied that the increase in membrane rigidity de- 
pended upon a transmembrane event and not upon a rigidity- 
inducing lattice on the outside surface of the cell. The hy- 
pothesis  that  ligand-induced  rigidity  is  a  transmembrane 
process is further strengthened by the current data on Milten- 
berger V erythrocytes. The inability of these cells to become 
rigid after antibody binding demonstrates that the cytoplas- 
mic domain of glycophorin A  must be present for ligand- 
induced membrane rigidity to occur. 
How can  we explain  the differential response to  ligand 
binding?  One  possible  model  that  we propose is  that  the 
binding of ligands  to  glycophorin A  induces a  conforma- 
tional change in the polypeptide that results in a change in 
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Figure 9.  Model of effect of ligand binding on glycophorin A. In 
the nonliganded state, the cytoplasmic domain of glycophorin A is 
free floating and not associated with the skeletal protein network. 
Ligand binding induces a conformational change which causes the 
cytoplasmic domain of  glycophorin to come into close contact with 
the skeletal protein lattice resulting either in entanglement in the lat- 
tice or in a specific protein-protein  interaction with a component 
of the lattice. Both of these occurrences  would cause increased 
membrane rigidity. Individual protein components of the skeletal 
network have not been delineated, since the exact nature of the in- 
teraction of liganded glycophorin A with any one specific compo- 
nent is unclear at the present time. 
the spatial relationship of the cytoplasmic domain of glyco- 
pborin  and  the  skeletal  protein network.  Precedence  for 
ligand-induced polypeptide conformational change  exists. 
Falke and Koshland have recently shown that transmembrane 
signaling by the aspartate receptor involves a global change 
in the structure of the protein (14). In our model, shown in 
Fig. 9, in the nonliganded state the conformation of glyco- 
phorin A is such that its cytoplasmic domain is free floating 
and is not associated with the skeletal protein network. This 
protein network, depicted in the model in simplified form, 
is actually a complex group of interacting skeletal proteins 
which includes spectrin, actin, adducin, tropomyosin, and 
proteins 4.1 and 4.9. The binding of a ligand to the extracel- 
lular domain of glycophorin induces a change in the confor- 
mation of  the molecule which causes the cytoplasmic domain 
to come into close contact with this skeletal protein network. 
This, in turn, results in increased protein-protein associa- 
tions leading to increased membrane rigidity. The differen- 
tial response to various ligands can then be envisioned to 
result  from differences in  the  molecular conformation of 
glycophorin induced by these ligands which in turn might ~le- 
termine the number of glycophorin molecules that come into 
close contact with the skeletal protein network. We suggest 
that the  greater the  extent of conformational change,  the 
higher the likelihood of glycophorin molecules becoming 
associated with skeletal proteins and the larger the increase 
in membrane rigidity. In support of this model are our results 
showing  the  direct relationship  between  increased  mem- 
brane rigidity and increased association of glycophorin A 
with skeletal proteins in the Triton shells. It is interesting to 
note that there were only small increases in the amount of 
glycophorin A associated with the skeletal proteins despite 
marked increases in rigidity. There are at least two possible 
explanations for these results. First, it may be that a small 
number of copies of glycophorin becoming associated with 
the membrane skeleton is indeed sufficient to account for the 
observed increases  in  membrane  rigidity.  There is  some 
precedent for small increases in the number of protein-pro- 
tein associations within the membrane skeleton leading to in- 
creased  rigidity.  Previous  investigators  have  observed  a 
three- to four-fold increase in membrane rigidity associated 
with  only a  3.7%  increase in  spectrin-hemoglobin cross- 
linking after treating erythrocyte membranes with hydrogen 
peroxide (35). Alternatively, it may be that only high affinity 
associations between glycophorin and the membrane skele- 
ton can be detected by the technique we applied,  and that 
lower affinity associations are also occurring which contrib- 
ute to the increased rigidity. At this time, we cannot distin- 
guish between these possibilities. 
It is also unclear at the present time whether the increased 
association of glycophorin A with the skeletal protein lattice 
is due to specific binding to a component of the lattice, or 
alternatively, whether it is due to physical entanglement of 
the  cytoplasmic domain  within the  lattice.  Anderson and 
Lovrien have previously shown that the cytoplasmic domain 
of glycophorin A can bind to protein 4.1, and further charac- 
terization of  this binding by Anderson and Marchesi suggests 
that it is regulated by the phosphoinositides (2, 3). However, 
studies of En(a-) erythrocytes, which are deficient in glyco- 
phorin A,  showed that these cells had normal  membrane 
deformability and membrane stability (30). Since the mem- 
brane properties of deformability and stability are regulated 
by the skeletal protein network, the observation that glyco- 
phorin A-deficient cells have normal membrane properties 
suggests that glycophorin A does not associate with skeletal 
proteins in the normal physiological state,  but does so only 
after ligand binding. These findings further support our pro- 
posed model in which the cytoplasmic domain of glycopho- 
rin A is free floating in the nonliganded state. 
Our  observation  that  ligand  binding  to  glycophorin C 
causes no increase in membrane rigidity is consistent with 
the report that this sialoglycoprotein, in contrast to glyco- 
phorin A, is already linked to the membrane skeleton via an 
interaction with protein 4.1  (27).  With an association of its 
cytoplasmic domain already in place, ligand binding would 
not be expected to induce new associations between this inte- 
gral protein and the skeletal protein lattice. 
The results presented here imply that glycophorin A  is 
capable of a novel form of signal transduction that is modu- 
lated by the domain specificity of the ligand. Furthermore, 
the data allow us to establish unequivocally that the cytoplas- 
mic domain of glycophorin A  is crucial for this signaling 
process.  Glycophorin A  may  hence  serve as  a  model  of 
modulatable transmembrane communication. It will be of 
interest to determine whether this  modulatable process is 
unique to glycophorin A or whether it is observed in other 
signaling proteins. 
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